Ver mas grande
CHPF N-Terminal antibody
FT-FNab01671
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | CHPF N-Terminal |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | chondroitin polymerizing factor |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Chondroitin sulfate synthase 2|Chondroitin glucuronyltransferase 2|Chondroitin-polymerizing factor (ChPF)|Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II|N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosylt |
| Host | Rabbit |
| UniProt ID | Q8IZ52 |
| Gene ID | 79586 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 85 kDa |
| Background | Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid(GlcUA) from UDP-GlcUA and N-acetylgalactosamine(GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Iso |
Más información
CHPF N-Terminal antibody